Experimental prestorage filtration removes antibodies and decreases lipids in RBC supernatants mitigating TRALI in vivo

Blood

Volumn 123, Issue 22, 2014, Pages 3488-3495

  Silliman, Christopher C ^a,b,c   Kelher, Marguerite R ^a,c   Khan, Samina Y ^a,b   LaSarre, Monica ^a   West, F Bernadette ^a   Land, Kevin J ^d   Mish, Barbara ^e   Ceriano, Linda ^e   Sowemimo Coker, Samuel ^f  

^a Bonfils Blood Center   (United States)

^b Children's Hospital Colorado   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d Blood Systems Incorporated   (United States)

^e PALL CORPORATION   (United States)

^f HAEMONETICS CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; 5 HYDROXYICOSATETRAENOIC ACID; ADENOSINE TRIPHOSPHATE; HLA A2 ANTIGEN; HLA ANTIBODY; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HUMAN NEUTROPHIL ANTIGEN 3A ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FILTRATION; CELL SURVIVAL; CONTROLLED STUDY; DONOR; ERYTHROCYTE; HUMAN; LEUKOCYTE ACTIVATION; LIPID STORAGE; LUNG LAVAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; NONHUMAN; PH; PRIORITY JOURNAL; RAT; SUPERNATANT; TRANSFUSION RELATED ACUTE LUNG INJURY;

2,3-DIPHOSPHOGLYCERATE; ACUTE LUNG INJURY; ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIBODIES; BLOOD COMPONENT REMOVAL; BLOOD COMPONENT TRANSFUSION; BLOOD DONORS; ERYTHROCYTES; FEMALE; FILTRATION; HLA ANTIGENS; HUMANS; HYDROGEN-ION CONCENTRATION; LEUKOCYTES, MONONUCLEAR; LIPIDS; MALE; PLASMA; RATS;

EID: 84901710322     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-10-532424     Document Type: Article

References (47)

1. Chapman CE, Stainsby D, Jones H, et al.; Serious Hazards of Transfusion Steering Group. Ten years of hemovigilance reports of transfusion related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion. 2009;49(3):440-452.
2. Hendrickson JE, Hillyer CD. Noninfectious serious hazards of transfusion. Anesth Analg. 2009; 108(3):759-769.
3. Holness L, Knippen MA, Simmons L, Lachenbruch PA. Fatalities caused by TRALI. Transfus Med Rev. 2004;18(3):184-188. (Pubitemid 38962487)
4. Eder AF, Dy BA, Perez JM, Rambaud M, Benjamin RJ. The residual risk of transfusion related acute lung injury at the American Red Cross (2008-2011): limitations of a predominantly male-donor plasma mitigation strategy. Transfusion. 2013;53(7):1442-1449.
5. Zupanska B, Uhrynowska M, Michur H, Maslanka K, Zajko M. Transfusion-related acute lung injury and leucocyte-reacting antibodies. Vox Sang. 2007;93(1):70-77. (Pubitemid 46850710)
6. Kelher MR, Masuno T, Moore EE, et al. Plasma from stored packed red blood cells and MHC class I antibodies causes acute lung injury in a 2-event in vivo rat model. Blood. 2009;113(9):2079-2087.
7. Kelher MR, Silliman CC. Antibodies specific for MHC class II antigens cause TRALI directly in a two-event in vivo model [abstract]. Blood. 2012; 120(21). Abstract 845.
8. Khan SY, Kelher MR, Heal JM, et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood. 2006; 108(7):2455-2462. (Pubitemid 44497533)
9. Kopko PM, Popovsky MA. Pulmonary injury from transfusion-related acute lung injury. Clin Chest Med. 2004;25(1):105-111. (Pubitemid 38296336)
10. Looney MR, Gilliss BM, Matthay MA. Pathophysiology of transfusion-related acute lung injury. Curr Opin Hematol. 2010;17(5):418-423.
11. Popovsky MA. Transfusion related acute lung injury. In: Popovsky MA, ed. Transfusion Reactions. Bethesda, MD: AABB Press; 2001: 155-170.
12. Sachs UJ. A threshold model for the susceptibility to transfusion-related acute lung injury. Transfus Clin Biol. 2012;19(3):109-116.
13. Silliman CC, Boshkov LK, Mehdizadehkashi Z, et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood. 2003;101(2):454-462. (Pubitemid 36077563)
14. Silliman CC. The two-event model of transfusion related acute lung injury. Crit Care Med. 2006; 34(5, suppl):S124-S131. (Pubitemid 43670479)
15. Van Buren NL, Stroncek DF, Clay ME, McCullough J, Dalmasso AP. Transfusion-related acute lung injury caused by an NB2 granulocyte specific antibody in a patient with thrombotic thrombocytopenic purpura. Transfusion. 1990; 30(1):42-45. (Pubitemid 20037304)
16. Blumberg N, Heal JM, Gettings KF, et al. An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions. Transfusion. 2010;50(12):2738-2744.
17. Gilliss BM, Looney MR, Gropper MA. Reducing noninfectious risks of blood transfusion. Anesthesiology. 2011;115(3):635-649.
18. Bowden RA, Slichter SJ, Sayers M, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion associated CMV infection after marrow transplant. Blood. 1995;86(9):3598-3603.
19. Hébert PC, Fergusson D, Blajchman MA, et al.; Leukoreduction Study Investigators. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. JAMA. 2003;289(15): 1941-1949. (Pubitemid 37430225)
20. Silliman CC, Moore EE, Kelher MR, Khan SY, Gellar L, Elzi DJ. Identification of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury. Transfusion. 2011; 51(12):2549-2554.
21. Kopko PM, Popovsky MA, MacKenzie MR, Paglieroni TG, Muto KN, Holland PV. HLA class II antibodies in transfusion-related acute lung injury. Transfusion. 2001;41(10):1244-1248. (Pubitemid 33000960)
22. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion. 1985;25(6): 573-577. (Pubitemid 16174471)
23. Silliman CC, Fung YL, Ball JB, Khan SY. Transfusion-related acute lung injury (TRALI): current concepts and misconceptions. Blood Rev. 2009;23(6):245-255.
24. Wyman TH, Bjornsen AJ, Elzi DJ, et al. A two insult in vitro model of PMN-mediated pulmonary endothelial damage: requirements for adherence and chemokine release. Am J Physiol Cell Physiol. 2002;283(6):C1592-C1603. (Pubitemid 35340590)
25. Silliman CC, Clay KL, Thurman GW, Johnson CA, Ambruso DR. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med. 1994;124(5):684-694.
26. Sowemimo-Coker SO. Evaluation of an experimental filter designed for improving the quality of red blood cells (RBCs) during storage by simultaneously removing white blood cells and immunomodulators and improving RBC viscoelasticity and Band 3 proteins. Transfusion. 2014;54(3):592-601.
27. Silliman CC, Kelher M, Ambruso DR. Bioactive lipids from stored cellular blood components: in vitro method is crucial for proper interpretation. Transfusion. 2012;52(5):1155-1157, author reply 1157-1158.
28. Bercovitz RS, Kelher MR, Khan SY, Land KJ, Berry TH, Silliman CC. The pro-inflammatory effects of platelet contamination in plasma and mitigation strategies for avoidance. Vox Sang. 2012;102(4):345-353.
29. Fuggle SV, Martin S. Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients. Transplantation. 2008;86(3):384-390.
30. Kopko PM, Marshall CS, MacKenzie MR, Holland PV, Popovsky MA. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA. 2002;287(15):1968-1971. (Pubitemid 34309755)
31. Lee HB, Blaufox MD. Blood volume in the rat. J Nucl Med. 1985;26(1):72-76. (Pubitemid 15161428)
32. Bercovitz RS, Khan SY, Kelher MR, et al. Anti-HLA antibodies cause neutrophil priming in HLA-A2 hmomzygotes [abstract]. Transfusion. 2010;50(suppl s2):121A-122A. Abstract SP171.
33. Silliman CC, Curtis BR, Kopko PM, et al. Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model. Blood. 2007;109(4):1752-1755. (Pubitemid 46239611)
34. Vlaar AP, Kulik W, Nieuwland R, et al. Accumulation of bioactive lipids during storage of blood products is not cell but plasma derived and temperature dependent. Transfusion. 2011; 51(11):2358-2366.
35. Goldyne ME, Burrish GF, Poubelle P, Borgeat P. Arachidonic acid metabolism among human mononuclear leukocytes. Lipoxygenase-related pathways. J Biol Chem. 1984;259(14):8815-8819. (Pubitemid 14053304)
36. Dzieciatkowska M, Silliman CC, Moore EE, et al. Proteomic analysis of the supernatant of red blood cell units: the effects of storage and leucoreduction. Vox Sang. 2013;105(3):210-218.
37. National Center for Biotechnology Information. Basic local alignment search tool. http://blast.ncbi.nlm.nih.gov/Blast.cgi. Accessed February 24, 2014.
38. Silliman CC, Moore EE, Johnson JL, Gonzalez RJ, Biffl WL. Transfusion of the injured patient: proceed with caution. Shock. 2004;21(4):291-299.
39. Vlaar AP, Hofstra JJ, Levi M, et al. Supernatant of aged erythrocytes causes lung inflammation and coagulopathy in a "two-hit" in vivo syngeneic transfusion model. Anesthesiology. 2010;113(1): 92-103.
40. Vlaar AP, Hofstra JJ, Kulik W, et al. Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model. Blood. 2010;116(8):1360-1368.
41. Eder AF, Herron RM Jr, Strupp A, et al. Effective reduction of transfusion-related acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006-2008). Transfusion. 2010;50(8):1732-1742.
42. Toy P, Gajic O, Bacchetti P, et al.; TRALI Study Group. Transfusion-related acute lung injury: incidence and risk factors. Blood. 2012;119(7): 1757-1767.
43. Lacroix J, Hébert P, Fergusson D, et al.; ABLE study group. The Age of Blood Evaluation (ABLE) randomized controlled trial: study design. Transfus Med Rev. 2011;25(3):197-205.
44. Spinella PC. Age of Blood PICU. www.sabm.org/sites/www.sabm.org/files/ AgeofBlood-PICU.pdf. Accessed July 10, 2012.
45. Zallen G, Offner PJ, Moore EE, et al. Age of transfused blood is an independent risk factor for postinjury multiple organ failure. Am J Surg. 1999; 178(6):570-572. (Pubitemid 30058313)
46. Arnold DM, Molinaro G, Warkentin TE, et al. Hypotensive transfusion reactions can occur with blood products that are leukoreduced before storage. Transfusion. 2004;44(9):1361-1366. (Pubitemid 39129251)
47. Mangalmurti NS, Xiong Z, Hulver M, et al. Loss of red cell chemokine scavenging promotes transfusion-related lung inflammation. Blood. 2009;113(5):1158-1166.